Search
for

    Research 10 of 41

    1. NEW FORMULATIONS: Glatiramer acetate Australian Prescriber · 2004
    2. Disease-Modifying Therapy in Multiple Sclerosis: Strategies For Optimizing Management The Neurologist · 2002 · 45 citations
    3. BH25 Alopecia in a patient undergoing multiple treatments for multiple sclerosis: a rare presentation and case review British Journal of Dermatology · 2025
    4. Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management Expert Review of Neurotherapeutics · 2006 · 18 citations
    5. Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis Neurodegenerative disease management · 2013
    6. Disease modifying agent related skin reactions in multiple sclerosis: prevention, assessment, and management Multiple Sclerosis Journal · 2004 · 37 citations
    7. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis Expert Opinion on Pharmacotherapy · 2014 · 16 citations
    8. NEW PROPRIETARY BRANDS: Gabapentin Australian Prescriber · 2004
    9. NEW PROPRIETARY BRANDS: Cephalexin Australian Prescriber · 2004
    10. New drugs: Agalsidase beta Australian Prescriber · 2004
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →